Title: Method and system for verifying the integrity of normal sinus rhythm templates
Abstract: A method and system for verifying the integrity of normal sinus rhythm (NSR) templates and updating the NSR template after selected time intervals. At selected time intervals after establishing a NSR template, cardiac complexes are sensed and values for one or more cardiac parameters are measured. The values of the cardiac parameters are compared to predetermined value ranges for NSR cardiac complexes. When the values of the cardiac parameters fall within the predetermined value ranges, values for the differences between the values of the cardiac parameters for the cardiac complexes and the values for the cardiac parameters of the NSR cardiac complexes are calculated. When the values of the differences are greater than one or more threshold values, the NSR template is updated as a function of the sensed cardiac complexes.
Patent Number: 6,996,434 Issued on 02/07/2006 to Marcovecchio,   et al.
| Inventors:
|
Marcovecchio; Alan F. (Minneapolis, MN);
Hsu; William (Circle Pines, MN)
|
| Assignee:
|
Cardiac Pacemakers, Inc. (St. Paul, MN)
|
| Appl. No.:
|
921348 |
| Filed:
|
August 2, 2001 |
| Current U.S. Class: |
600/509 |
| Current Intern'l Class: |
A61B 5/04 (20060101) |
| Field of Search: |
600/513,509
|
References Cited [Referenced By]
U.S. Patent Documents
| 4023564 | May., 1977 | Valiquette et al.
| |
| 4316249 | Feb., 1982 | Gallant et al.
| |
| 4531527 | Jul., 1985 | Reinhold, Jr. et al.
| |
| 4583553 | Apr., 1986 | Shah et al.
| |
| 4589420 | May., 1986 | Adams et al.
| |
| 4721114 | Jan., 1988 | DuFault et al.
| |
| 4924875 | May., 1990 | Chamoun.
| |
| 5000189 | Mar., 1991 | Throne et al.
| |
| 5014284 | May., 1991 | Langer et al.
| |
| 5020540 | Jun., 1991 | Cahmoun.
| |
| 5107850 | Apr., 1992 | Olive.
| |
| 5109842 | May., 1992 | Adinolfi.
| |
| 5139028 | Aug., 1992 | Steinhaus et al.
| |
| 5156148 | Oct., 1992 | Cohen.
| |
| 5184615 | Feb., 1993 | Nappholz et al.
| |
| 5193550 | Mar., 1993 | Duffin.
| |
| 5215098 | Jun., 1993 | Steinhaus et al.
| |
| 5240009 | Aug., 1993 | Williams.
| |
| 5247021 | Sep., 1993 | Fujisawa et al.
| |
| 5255186 | Oct., 1993 | Steinhaus et al.
| |
| 5269301 | Dec., 1993 | Cohen.
| |
| 5271411 | Dec., 1993 | Ripley et al.
| |
| 5273049 | Dec., 1993 | Steinhaus et al.
| |
| 5280792 | Jan., 1994 | Leong et al.
| |
| 5292348 | Mar., 1994 | Saumarez et al.
| |
| 5311874 | May., 1994 | Baumann et al.
| |
| 5312445 | May., 1994 | Nappholz et al.
| |
| 5313953 | May., 1994 | Yomtov et al.
| |
| 5330504 | Jul., 1994 | Somerville et al.
| |
| 5331966 | Jul., 1994 | Bennett et al.
| |
| 5342402 | Aug., 1994 | Olson et al.
| |
| 5350406 | Sep., 1994 | Nitzsche et al.
| |
| 5360436 | Nov., 1994 | Alt et al.
| |
| 5388578 | Feb., 1995 | Yomtov et al.
| |
| 5400795 | Mar., 1995 | Murphy et al.
| |
| 5411031 | May., 1995 | Yomtov.
| |
| 5421830 | Jun., 1995 | Epstein et al.
| |
| 5447519 | Sep., 1995 | Peterson.
| |
| 5447524 | Sep., 1995 | Alt.
| |
| 5456261 | Oct., 1995 | Luczyk.
| |
| 5458623 | Oct., 1995 | Lu et al.
| |
| 5478807 | Dec., 1995 | Cronin et al.
| |
| 5509927 | Apr., 1996 | Epstein et al.
| |
| 5520191 | May., 1996 | Karlsson et al.
| |
| 5542430 | Aug., 1996 | Farrugia et al.
| |
| 5549641 | Aug., 1996 | Ayers et al.
| |
| 5622178 | Apr., 1997 | Gilham.
| |
| 5634468 | Jun., 1997 | Platt et al.
| |
| 5645070 | Jul., 1997 | Turcott.
| |
| 5682900 | Nov., 1997 | Arand et al.
| |
| 5683425 | Nov., 1997 | Hauptmann.
| |
| 5687737 | Nov., 1997 | Branham et al.
| |
| 5712801 | Jan., 1998 | Turcott.
| |
| 5713367 | Feb., 1998 | Arnold et al.
| |
| 5724985 | Mar., 1998 | Snell et al.
| |
| 5730142 | Mar., 1998 | Sun et al.
| |
| 5755739 | May., 1998 | Sun et al.
| |
| 5759158 | Jun., 1998 | Swanson.
| |
| 5772604 | Jun., 1998 | Langberg et al.
| |
| 5778881 | Jul., 1998 | Sun et al.
| |
| 5779645 | Jul., 1998 | Olson et al.
| |
| 5782888 | Jul., 1998 | Sun et al.
| |
| 5792065 | Aug., 1998 | Xue et al.
| |
| 5795303 | Aug., 1998 | Swanson et al.
| |
| 5797399 | Aug., 1998 | Morris et al.
| |
| 5797849 | Aug., 1998 | Vesely et al.
| |
| 5817133 | Oct., 1998 | Houben.
| |
| 5819007 | Oct., 1998 | Elghazzawi.
| |
| 5819741 | Oct., 1998 | Karlsson et al.
| |
| 5848972 | Dec., 1998 | Triedman et al.
| |
| 5858977 | Jan., 1999 | Aukerman et al.
| |
| 6076014 | Jun., 2000 | Alt.
| |
| 6096061 | Aug., 2000 | Alt et al.
| |
| 6223078 | Apr., 2001 | Marcovecchio.
| |
| 6266554 | Jul., 2001 | Hsu et al.
| |
| 6275732 | Aug., 2001 | Hsu et al.
| |
| 6308095 | Oct., 2001 | Hsu et al.
| |
| 6312388 | Nov., 2001 | Marcovecchio et al.
| |
| 6314321 | Nov., 2001 | Morris.
| |
| 6353759 | Mar., 2002 | Hartley et al.
| |
| 6411848 | Jun., 2002 | Kramer et al.
| |
| 6430435 | Aug., 2002 | Hsu et al.
| |
| 6430438 | Aug., 2002 | Chen et al.
| |
| 6434417 | Aug., 2002 | Lovett.
| |
| 6438410 | Aug., 2002 | Hsu et al.
| |
| 6442425 | Aug., 2002 | Alt.
| |
| 6449503 | Sep., 2002 | Hsu.
| |
| 6484055 | Nov., 2002 | Marcovecchio.
| |
| 6687540 | Feb., 2004 | Marcovecchio.
| |
| 6708058 | Mar., 2004 | Kim et al.
| |
| 6728572 | Apr., 2004 | Hsu et al.
| |
| 6889081 | May., 2005 | Hsu.
| |
| 2002/0032469 | Mar., 2002 | Marcovecchio.
| |
| 2002/0091333 | Jul., 2002 | Hsu et al.
| |
| 2002/0183637 | Dec., 2002 | Kim et al.
| |
| 2002/0183639 | Dec., 2002 | Sweeney et al.
| |
| 2003/0181818 | Sep., 2003 | Kim et al.
| |
| 2004/0093035 | May., 2004 | Schwartz et al.
| |
| 2004/0116972 | Jun., 2004 | Marcovecchio.
| |
| 2004/0127806 | Jul., 2004 | Sweeney.
| |
| 2004/0176694 | Sep., 2004 | Kim et al.
| |
| Foreign Patent Documents |
| 4405827 | Jun., 1995 | DE.
| |
| 0554208 | Aug., 1993 | EP.
| |
| 0711531 | May., 1996 | EP.
| |
| 0776631 | Nov., 1996 | EP.
| |
| 0848965 | Jun., 1998 | EP.
| |
| 97/39681 | Apr., 1996 | WO.
| |
Other References
Duru, Firat, et al., "The Potential for Inappropriate Ventricular Tachycardia
Confirmation Using the Intracardiac Electrogram (EGM) Width Criterion", PACE,
vol. 22, (Jul. 1999), 1039-1046.
Ellenbogen, Kenneth A., "Cardiac Pacing", Cambridge, Mass., USA : Blackwell
Science, 2nd ed., (1996),311-312 & 435-437.
Grady, Thomas A., et al., "Prognostice Significance of Exercise-Induced Left
Bundle-Branch Block", JAMA, vol. 279, No. 2, Jan. 14, 1998, 153-156.
Kinoshita, Shinji, et al., "Transient Disapperance of Complete Right Bundle Branch
(BBB) During Exercise", Journal of Electrocardiology, vol. 29, No. 3, 1996, 255-256.
Li, Dan , "Methods and Apparatuses for Cardiac Arrhythmia Classification Using
Morphology Stability", U.S. Appl. No. 11/038,996, Filed Jan. 20, 2005, 74 pgs.
IEEE, "Microcomputer-Based Telemetry System for ECG Monitoring", IEEE Proc.
of the Ann. Int'l Conf. of the Engineering in Medicine and Biology Society, vol.
Conf. 8, XP000015425, 1492-193, (1987).
|
Primary Examiner: Bockelman; Mark
Attorney, Agent or Firm: Schwegman, Lundberg, Woessner & Kluth, P.A.
Parent Case Text
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a continuation of U.S. patent application Ser. No. 09/267,306,
filed on Mar. 12, 1999, now issued as U.S. Pat. No. 6,312,388, the specification
of which is incorporated herein by reference.
Claims
What is claimed is:
1. A method, comprising:
comparing one or more sensed cardiac complex parameter values to one or more
predetermined cardiac complex parameter values;
determining whether the one or more sensed cardiac complex parameter values and
the one or more predetermined cardiac complex parameter values have differences
greater than a threshold; and
updating a normal sinus rhythm (NSR) template upon determining that the one or
more sensed cardiac complex parameter values and the one or more predetermined
cardiac complex parameter values have differences that are greater than the threshold.
2. The method of claim 1, further comprising retaining the NSR template upon
determining that the one or more sensed cardiac complex parameter values and the
one or more predetermined cardiac complex parameter values do not have differences
that are greater than the threshold.
3. The method of claim 1, further comprising determining whether the one or more
sensed cardiac complex parameter values are within one or more ranges of normal
values prior to comparing the one or more sensed cardiac complex parameter values
to the one or more predetermined cardiac complex parameter values, wherein the
one or more sensed cardiac complex parameter values are compared upon determining
that the one or more sensed cardiac complex parameter values are within the one
or more ranges of normal values.
4. The method of claim 3, further comprising:
upon determining that the one or more sensed cardiac complex parameter values
are not within the one or more ranges of normal values, determining whether a maximum
number of attempts has been made to evaluate the one or more sensed cardiac complex
parameter values; and
upon determining that the maximum number of attempts has been made, retaining
the NSR template.
5. The method of claim 1, further comprising waiting a selected time period before
comparing the one or more sensed cardiac complex parameter values to one or more
predetermined cardiac complex parameter values and determining whether the one
or more sensed cardiac complex parameter values and the one or more predetermined
cardiac complex parameter values have differences greater than a threshold.
6. The method of claim 5, wherein comparing one or more sensed cardiac complex
parameter values to one or more predetermined cardiac complex parameter values
and determining whether the one or more sensed cardiac complex parameter values
and the one or more predetermined cardiac complex parameter values have differences
greater than a threshold are automatically performed after the selected time period.
7. The method of claim 1, wherein comparing one or more sensed cardiac complex
parameter values and determining whether the one or more sensed cardiac complex
parameter values and the one or more predetermined cardiac complex parameter values
have differences greater than a threshold are performed after receiving a physician-initiated command.
8. The method of claim 1, wherein comparing one or more sensed cardiac complex
parameter values to one or more predetermined cardiac complex parameter values
includes comparing one or more sensed cardiac complex parameter values to one or
more physician-programmed values.
9. The method of claim 1, wherein comparing one or more sensed cardiac complex
parameter values to one or more predetermined cardiac complex parameter values
includes comparing one or more sensed cardiac complex parameter values to one or
more values derived from a current NSR template.
10. The method of claim 1, further comprising creating an initial NSR template
which is updated when the sensed cardiac complex parameter values and the predetermined
cardiac complex parameter values have differences that are greater than the threshold.
11. The method of claim 10, wherein creating an initial NSR template includes:
determining whether one or more sensed cardiac complex parameter values are within
one or more ranges of normal parameter values; and
setting the initial NSR template based on the one or more sensed cardiac complex
parameter values.
12. The method of claim 11, further comprising displaying a proposed NSR template,
and determining whether the proposed NSR template is approved prior to setting
the initial NSR template.
13. The method of claim 11, further comprising:
upon determining that the one or more sensed cardiac complex parameter values
are not within one or more ranges of normal parameter values, determining whether
a maximum number of attempts has been made to evaluate the one or more sensed cardiac
complex parameter values; and
upon determining that a maximum number of attempts has been made, redefining
one or more ranges of acceptable parameter values.
14. The method of claim 1, wherein updating a NSR template comprises setting
an updated NSR template based on the sensed cardiac complex parameter values.
15. The method of claim 14, further comprising displaying a proposed NSR template,
and determining whether the proposed NSR template is approved prior to setting
the updated NSR template.
16. A method, comprising:
creating a normal sinus rhythm (NSR) template;
determining whether sensed cardiac complex parameter values are within a range
of normal values;
upon determining that the sensed cardiac complex parameter values are within
a range of normal values, comparing the sensed cardiac complex parameter values
to predetermined cardiac complex parameter values;
determining whether the sensed cardiac complex parameter values and the predetermined
cardiac complex parameter values have differences greater than a threshold; and
updating the NSR template upon determining that the sensed cardiac complex parameter
values and the predetermined cardiac complex parameter values have differences
that are greater than the threshold.
17. The method of claim 16, further comprising:
upon determining that the sensed cardiac complex parameter values are not within
a range of normal values, determining whether a maximum number of attempts has
been made to evaluate the sensed cardiac complex parameter values; and
upon determining that the maximum number of attempts has been made, retaining
the NSR template.
18. The method of claim 16, further comprising waiting a selected time period
before comparing sensed cardiac complex parameter values to predetermined cardiac
complex parameter values and determining whether the sensed cardiac complex parameter
values and the predetermined cardiac complex parameter values have differences
greater than a threshold.
19. The method of claim 18, wherein comparing sensed cardiac complex parameter
values to predetermined cardiac complex parameter values and determining whether
the sensed cardiac complex parameter values and the predetermined cardiac complex
parameter values have differences greater than a threshold are automatically performed
after the selected time period.
20. The method of claim 18, wherein comparing sensed cardiac complex parameter
values to predetermined cardiac complex parameter values and determining whether
the sensed cardiac complex parameter values and the predetermined cardiac complex
parameter values have differences greater than a threshold are performed after
receiving a physician-initiated command.
21. The method of claim 16, wherein creating a NSR template includes:
determining whether sensed cardiac complex parameter values are within a range
of normal parameter values;
displaying a proposed NSR template based on the sensed cardiac complex parameter values;
determining whether the proposed NSR template is approved; and
setting the proposed NSR template as the NSR template.
22. The method of claim 16, wherein updating the NSR template upon determining
that the sensed cardiac complex parameter values and the predetermined cardiac
complex parameter values have differences that are greater than the threshold includes:
displaying a proposed updated NSR template;
determining whether the proposed updated NSR template is approved; and
upon determining that the proposed updated NSR template is approved, setting
the proposed updated NSR template an updated NSR template.
23. The method of claim 16, wherein comparing the sensed cardiac complex parameter
values to predetermined cardiac complex parameter values includes comparing sensed
cardiac complex parameter values to physician-programmed values.
24. The method of claim 16, wherein comparing the sensed cardiac complex parameter
values to predetermined cardiac complex parameter values includes comparing sensed
cardiac complex parameter values to values derived from the NSR template.
Description
FIELD OF THE INVENTION
This invention relates generally to medical devices, and more particularly to
a system and method for verifying the integrity of normal sinus rhythm templates.
BACKGROUND
The heart is divided into four chambers, the left and right atrial chambers and
the left and right ventricular chambers. As the heart beats, the atrial chambers
and the ventricular chambers go through a cardiac cycle. The cardiac cycle consists
of one complete sequence of contraction and relaxation of the chambers of the heart.
The terms systole and diastole are used to describe the contraction and relaxation
phases the chambers of the heart experience during a cardiac cycle. In systole,
the ventricular muscle cells contract to pump blood through the circulatory system.
During diastole, the ventricular muscle cells relax, causing blood from the atrial
chamber to fill the ventricular chamber. After the period of diastolic filling,
the systolic phase of a new cardiac cycle is initiated.
Through the cardiac cycle, the heart pumps blood through the circulatory
system. Effective pumping of the heart depends upon five basic requirements. First,
the contractions of cardiac muscle must occur at regular intervals and be synchronized.
Second, the valves separating the chambers of the heart must fully open as blood
passes through the chambers. Third, the valves must not leak. Fourth, the contraction
of the cardiac muscle must be forceful. Fifth, the ventricles must fill adequately
during diastole.
When the contractions of the heart are not occurring at regular intervals or
are unsynchronized the heart is said to be arrhythmic. During an arrhythmia, the
heart's ability to effectively and efficiently pump blood is compromised. Many
different types of arrhythmias have been identified. Arrhythmias can occur in either
the atrial chambers or in the ventricular chambers of the heart.
Ventricular tachycardia is an arrhythmia that occurs in the ventricular
chambers of the heart. Ventricular tachycardias are typified by ventricular rates
between 120-250 and are caused by disturbances (electrical or mechanical) within
the ventricles of the heart. During a ventricular tachycardia, the diastolic filling
time is reduced and the ventricular contractions are less synchronized and therefore
less effective than normal. Ventricular tachycardias must be treated quickly in
order to prevent the tachycardia from degrading into a life threatening ventricular fibrillation.
Arrhythmias that occur in the atrial chambers of the heart are referred
to generally as supraventricular tachycardias. Supraventricular tachycardias include
atrial tachycardias, atrial flutter and atrial fibrillation. During certain supraventricular
tachycardias, aberrant cardiac signals from the atria drive the ventricles at a
very rapid rate. Such a situation occurs during paroxysmal atrial tachycardia.
This condition begins abruptly, lasts for a few minutes to a few hours, and then,
just as abruptly, disappears and the heart rate reverts back to normal.
Cardioverter-defibrillators, such as implantable cardioverter-defibrillators
(ICDs), have been shown to be effective in reducing the incidence of sudden cardiac
death. Sudden cardiac death is typically caused by either ventricular tachycardia
or ventricular fibrillation. Cardioverter-defibrillator systems operate by sensing
and analyzing cardiac signals and applying electrical energy to the heart when
either a ventricular tachycardia or ventricular fibrillation is detected.
One common way cardioverter-defibrillators detect cardiac arrhythmias is to sense
and analyze the rate of ventricular contractions. When the ventricular rate exceeds
a programmed threshold value, the cardioverter-defibrillator applies electrical
energy in one or more specific patterns to treat either the ventricular tachycardia
or ventricular fibrillation.
An additional method cardioverter-defibrillators use to detect cardiac arrhythmias
is to compare the morphology of sensed cardiac complexes to template cardiac complexes
representative of specific cardiac rhythms. As each cardiac complex is sensed,
it is compared to the template cardiac complexes in an effort to identify and classify
the sensed cardiac complex. Template cardiac complexes can be representative of
a variety of cardiac complexes, including ventricular tachycardias and normal sinus rhythm.
Template cardiac complexes are typically programmed into an implantable
medical device shortly before or after the device has been implanted into the patient.
Once the implantable medical device has been implanted into the patient, however,
the physiologic environment in which cardiac electrodes are placed (i.e., the heart)
begins to change. These changes can include an inflammatory response, localized
fibrosis around the implanted electrode and cardiac disease progression. These
physiological changes lead to a deterioration, or a change in the strength and
the morphology of the signal sensed by the implanted medical device. Additionally,
changes in a patient's medication regimen can also change the sensing of cardiac
signals by the implanted medical device. Therefore, cardiac complex templates developed
before or soon after implanting the medical device can become less useful, or reliable,
in the process of assessing and classifying unknown cardiac complexes.
Therefore, a need exists for addressing the changes in sensed cardiac
signals as the physiological environment surrounding implanted cardiac electrodes changes.
SUMMARY OF THE INVENTION
The present subject matter provides a system and method to verify sensed normal
sinus rhythm (NSR) cardiac complexes and to use the NSR cardiac complexes to update
a NSR template. The system and method can either function automatically after a
selected time interval has expired, or after commands have been delivered by a
physician. As a result of updating, cardiac complexes being compared to the NSR
template can be classified more accurately than if the cardiac complexes were compared
to a NSR template that had not been updated.
Initially, a NSR template is created. In one embodiment, the NSR template
is created by an implantable medical device, such as an implantable cardioverter
defibrillator, under the control of a patient's attending physician. In creating
a NSR template, cardiac complexes are sensed from a patient's heart. Values of
one or more cardiac parameters are measured from each of the sensed cardiac complexes.
In one embodiment, an implantable cardioverter defibrillator is used to sense cardiac
complexes and to measure the values of the cardiac parameters. Cardiac parameters
can include, but are not limited to, ventricular and atrial cycle lengths, widths
of ventricular depolarizations, atrioventricular conduction times, and R-wave amplitudes.
The values of the cardiac parameters measured from the cardiac complexes are
then compared to predetermined ranges for the values of the cardiac parameters
for normal sinus rhythm (NSR) complexes. Based on this comparison, the cardiac
complexes can be determined to be, or not to be, NSR cardiac complexes. When the
cardiac complexes are determined to be NSR complexes, a NSR templates is calculated
as a function of these NSR complexes.
After a selected time interval, the NSR template is examined to determine if
it continues to accurately reflect the NSR cardiac complexes being sensed from
the patient's heart. In one embodiment, values of cardiac parameters are measured
from sensed cardiac complexes in a predetermined set of cardiac complexes. The
values are then compared to predetermined value ranges. In one embodiment, the
predetermined value ranges are individually established and programmed for each
of the cardiac parameters. Values for each cardiac parameter measured are then
compared to the corresponding predetermined value range established for that particular
cardiac parameter.
When the values of the cardiac parameters are found to be within the predetermined
value ranges, values for cardiac signal parameter differences are then calculated.
The cardiac signal parameter difference values are calculated by taking the difference
of the values of the cardiac parameters from each of the sensed cardiac complexes
and the values of the cardiac parameters for the NSR template complexes. The values
of the cardiac signal parameter differences are then compared to threshold values.
In one embodiment, the threshold values for each of the cardiac signal parameter
differences are calculated by multiplying a predetermined deviation percentage
and each value of the cardiac parameters for the NSR cardiac complexes used to
calculate the NSR template.
Based on the comparison, when the values for the cardiac signal parameter differences
are found to be greater than the threshold values, the NSR template is updated
as a function of the cardiac complexes. Alternatively, when the values for the
cardiac signal parameter differences are found to be less than or equal to the
threshold values, the NSR template is not updated.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a flow chart illustrating one embodiment of the present subject matter;
FIG. 2 is a flow chart illustrating one embodiment of the present subject matter;
FIG. 3 is a schematic of an implantable medical device; and
FIG. 4 is one embodiment of a block diagram of an implantable medical device
according to the present subject matter.
DETAILED DESCRIPTION
In the following detailed description, reference is made to the accompanying
drawings
which form a part hereof and in which is shown by way of illustration specific
embodiments in which the invention can be practiced. These embodiments are described
in sufficient detail to enable those skilled in the art to practice and use the
invention, and it is to be understood that other embodiments may be utilized and
that electrical, logical, and structural changes may be made without departing
from the spirit and scope of the present invention. The following detailed description
is, therefore, not to be taken in a limiting sense and the scope of the present
invention is defined by the appended claims and their equivalents.
The embodiments illustrated herein are demonstrated in an implantable cardiac
defibrillator (ICD), which may include numerous defibrillation, pacing, and pulse
generating modes known in the art. However, these embodiments are illustrative
of some of the applications of the present system, and are not intended in an exhaustive
or exclusive sense. The concepts described herein can be used in a variety of applications
which will be readily appreciated by those skilled in the art upon reading and
understanding this description. For example, the present system is suitable for
implementation in a variety of implantable and external devices.
The present subject matter allows for medical devices to examine and to recalculate
or update a cardiac complex template. As previously discussed, medical device systems
can use a cardiac complex template to assess and classify sensed cardiac complexes.
Based on the classification of cardiac complexes, the medical device system can
generate commands to cause the delivery of therapy to a patient's heart.
The physiologic environment in which cardiac electrodes are placed (i.e., the
heart) changes from the moment the electrodes are implanted. Changes in the physiologic
environment can include an inflammatory response and localized fibrosis around
the implanted electrode due to the presence of the implanted electrode. These physiological
changes, and other changes in cardiac disease, can lead to deterioration in sensing
by the implanted medical device. Additionally, changes in a patient's medication
regimen can also change the sensing of cardiac signals by the implanted medical
device. Therefore, cardiac complex templates developed soon after implanting the
medical device can become less reliable in the process of assessing and classifying
unknown cardiac complexes.
The present subject matter allows for cardiac complex templates to be examined
and, if certain predetermined conditions are met, to be recalculated. Recalculating
cardiac complex templates can occur based on a determination that cardiac signals
sensed during a cardiac state for which there is a cardiac complex template are
no longer within a predetermined range of acceptability. In one embodiment, recalculation
of the cardiac complex template is performed at specific time intervals over the
life of the implantable medical device. Alternatively, the cardiac complex template
is recalculated, or updated, at the direction of an attending physician when the
physician determines the sensed cardiac signals have deviated sufficiently from
the cardiac complex template signals.
In one embodiment, the present subject matter is useful for recalculating normal
sinus rhythm (NSR) templates or models, such as the NSR template previously discussed.
NSR templates are used in systems and methods where morphological features from
cardiac signals sensed during a tachycardia event are compared to morphological
features for cardiac signals sensed during normal sinus rhythm (e.g., the NSR templates).
In one embodiment, procedures that compare values derived from NSR cardiac complexes
are referred to as NSR template based procedures. In one embodiment, NSR template
based procedures require that the NSR template be calculated, or derived at, from
a patient's NSR cardiac complexes. However, as discussed above, as the cardiac
tissue surrounding the cardiac leads change (e.g., as the tissue in which the lead
is embedded changes) sensing of the cardiac complexes changes. Thus, there is a
need for the NSR template to be updated after the medical device has been implanted.
Referring now to FIG. 1, there is shown an embodiment for creating a normal
sinus rhythm (NSR) template. The procedure for setting the NSR template is started
at
100. In one embodiment, the procedure for setting the NSR template is
initiated by the patient's attending physician. Once the procedure is started at
100, values for one or more NSR parameters representative of the patient's
normal sinus rhythm are set at
104. In one embodiment, the values of the
NSR parameters are set by and programmed into the implantable medical device by
the attending physician. In one embodiment, the values of the NSR parameters are
based on a patient's previously recorded cardiac data and/or the patient's cardiac
history. Alternatively, the values for the NSR parameters are a set of typical
values for the NSR parameters.
In one embodiment, the values for the NSR parameters are derived from, but not
limited to, the following cardiac parameters: ventricular cycle lengths (e.g.,
time between consecutively sense R-waves), atrial cycle lengths (e.g., time between
consecutively sense P-waves), standard deviation of a plurality of ventricular
cycle lengths, standard deviation of a plurality of atrial cycle lengths, width
of ventricular depolarizations as manifested in the ventricular electrogram, atrioventricular
conduction times, standard deviation of a plurality of atrioventricular conduction
times, and standard deviation of a plurality of R-wave amplitudes as manifested
in the ventricular electrogram. In one embodiment, the NSR parameters for which
values are derived are selected and programmed into the medical device system through
the use of a medical device programmer. In addition, the values for the NSR parameters
are also programmed into the medical device system through the use of the medical
device programmer.
After the values for the NSR parameters are set, these initial values must
be checked against the values for the cardiac parameters measured from the patient's
NSR cardiac complexes. At
108, one or more cardiac complexes are sensed
from cardiac signals sensed from the patient's heart. In one embodiment, the cardiac
signals are electrogram signals sensed through the use of the implanted medical
device, such as an ICD, and include cardiac complexes representative of at least
a portion of the cardiac cycle.
In one embodiment, the cardiac signals are viewed in real time on the display
screen of the external medical device programmer. As the cardiac signal scrolls
across the display screen, the user can select a series of cardiac complexes which
he or she believes to be NSR complexes. The selected cardiac complexes are then
tested against the initial values of the NSR parameters. This procedure saves valuable
time by allowing only those cardiac complexes believed to be NSR complexes to be
checked against the initial cardiac parameter values.
The implanted medical device measures and stores values for the one or more cardiac
parameters from each of the sensed cardiac complexes. In one embodiment, the values
for the one or more cardiac parameters are taken, or derived, from the cardiac
parameters whose values were initially set at
104. At
112, the values
of the one or more cardiac parameters are used to determine whether the sensed
cardiac complexes are normal sinus rhythm (NSR) complexes. In one embodiment, the
values of the one or more cardiac parameters are compared to values of the corresponding
NSR parameters. In one embodiment, the values of the NSR parameters are those initially
set at
104. In an alternative embodiment, the values of the NSR parameters
are values of one or more cardiac parameters acquired during the process of setting
the NSR template, an embodiment which will be described in greater detail below.
At
112, if the values of the cardiac signal parameters fall within a predetermined
range of the values for the NSR parameters, then the NSR template and the values
for the NSR parameters are displayed at
116. In one embodiment, displaying
the NSR template and the values of the NSR parameters is done on the screen of
the medical device programmer. Alternatively, the NSR template and the values of
the NSR parameters are displayed on any suitably enabled display screen from which
this information can be viewed.
The NSR template is calculated as a function of sensed NSR cardiac complexes.
In one embodiment, after qualified NSR complexes have been identified, a single
NSR complex can be formed to represent multiple NSR complexes. This is done by
taking a sample by sample median, mean, or other statistic of one through n sensed
NSR complexes, where n is an integer value representing the number of sensed NSR
complexes. In one embodiment, n is an integer value in the range of 2 to 20 NSR complexes.
As the one through n NSR complexes are sensed, they are aligned around a common
feature of the cardiac signal. In one embodiment, the common feature is a maximum
deflection point of the cardiac signal as sensed during the occurrence of the ventricular
R-wave. Other common features of the cardiac complexes can also be used to align
the sensed NSR complexes. Once the NSR complexes have been aligned, median or mean
values of the cardiac complexes are used to calculate the NSR template. Once the
NSR template has been created from the sample by sample process, values for the
NSR features are extracted from the NSR template and stored for use with the present
subject matter. In an alternative embodiment, values for NSR features are measured
for each of the sensed one through n NSR complexes. Median or mean values for the
NSR feature values are calculated and the median or mean values are used to calculate
the NSR template.
Once the NSR template and the values for the NSR parameter have been displayed,
the attending physician can review the information. At
120, the physician
can either approve of or not approve of the NSR template and the values for the
NSR parameters proposed for use in the medical device. If the NSR template and
the values for the NSR parameters are approved at
120, the NSR template
and the values for the NSR parameters are programmed into the medical device system
at
124 for subsequent use in discrimination procedures which rely on NSR
templates and values of NSR parameters to distinguish one arrhythmic event from another.
If, however, the values of the cardiac signal parameters do not fall within values
of the NSR parameters at
112 or the user does not approve of the NSR template
and/or the values of the NSR parameters at
120, the system proceeds to
128.
At
128, the number of attempts at setting the NSR template is determined.
In one embodiment, when
128 is reached a value of one is added to the va